Back
Heineken Holding NV Vs. Spyre Therapeutics Industry Stock Comparison
Sell
30
HKHHF
Heineken Holding NV
Last Price:
78.19
Seasonality Move:
1.46%
Sell
28
SYRE
Spyre Therapeutics
Last Price:
22.71
Seasonality Move:
49.76%
Sell
30
Heineken Holding NV (HKHHF)
is a Sell
Is Heineken Holding NV a Buy, Sell or Hold?
- The current Heineken Holding NV [HKHHF] share price is $80.44. The Score for HKHHF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- HKHHF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $23.39. The Score for SYRE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HKHHF Stock Price Chart
What is Heineken Holding NV's stock price today?
-
The Heineken Holding NV share price today is $80.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HKHHF is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $23.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight buying pressure.
HKHHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 43.45 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.31 - 82.85) | Sell |
| Bollinger Bands (100): | (77.87 - 82.49) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.1 | Sell |
| Relative Strength Index (14 RSI): | 29.8 | Sell |
| Chaikin Money Flow: | 200039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.91 - 36.47) | Sell |
| Bollinger Bands (100): | (27.05 - 39.23) | Sell |
HKHHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.22 | Sell |
| 20-day SMA: | 81.26 | Sell |
| 50-day SMA: | 81.09 | Sell |
| 200-day SMA: | 79.32 | Buy |
| 8-day EMA: | 81.05 | Sell |
| 20-day EMA: | 81.35 | Sell |
| 50-day EMA: | 81.1 | Sell |
| 200-day EMA: | 80.63 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.36 | Sell |
| 20-day SMA: | 31.09 | Sell |
| 50-day SMA: | 33.45 | Sell |
| 200-day SMA: | 24.51 | Sell |
| 8-day EMA: | 25.8 | Sell |
| 20-day EMA: | 29.51 | Sell |
| 50-day EMA: | 32.17 | Sell |
| 200-day EMA: | 27.01 | Sell |
Heineken Holding NV Earnings Growth & HKHHF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Heineken Holding NV Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||